- Alzheimer's disease amyloid protein vaccine
- Breast cancer vaccine
- Ovarian cancer vaccine
- Prostate cancer vaccine
Infectious diseases are illnesses caused by pathogenic microorganisms like bacteria, viruses, fungi, or parasites. These diseases can spread directly or indirectly from person to person, through contaminated food or water, insect bites, or airborne transmission. Common examples include influenza, tuberculosis, COVID-19, malaria, and HIV/AIDS.
On the other hand, non-infectious diseases are not caused by infectious agents and are typically not contagious. These conditions often arise due to genetic factors, lifestyle choices, environmental exposures, or a combination of these factors. Non-infectious diseases encompass a broad range of health issues such as cardiovascular diseases (like heart disease and stroke), cancer, diabetes, autoimmune disorders, allergies, mental health disorders, and chronic respiratory conditions like asthma.
While infectious diseases are characterized by the presence and spread of pathogens, non-infectious diseases primarily arise from internal dysfunctions, external factors, or a combination of both. Both types of diseases have significant impacts on individual health, public health, and healthcare systems, albeit through different mechanisms of origin and transmission.
Khursheed Anwer
IMUNON, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Khursheed Anwer
IMUNON, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Lara Isis Teodoro
Mayo Clinic, United States
Ahmed Abdulazeez
BHRUT Trust, United Kingdom
Elena Chiappini
University of Florence, ItalySubmit your abstract Today
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology Analysis of MPXV and VACV Peptides Underscores the Need to Consider Both MPXV Clades for Vaccine Development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Awareness and acceptability of rotavirus vaccine among mothers of under-five children in Gusau and Bungudu communities of Zamfara state, northwestern Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil